Metabolism of unsaturated fatty acids and their importance in circulatory system prophylaxis and therapy;Metabolizm nienasyconych kwasów tłuszczowych i ich znaczenie w profilaktyce i terapii układu krwionośnego

Przeglad Kardiodiabetologinczny

Volumn 4, Issue 2, 2009, Pages 55-63

  Jablonska Trypuc, Agata ^a   Czerpak, Romuald ^a  

^a Wyzsza Szkoła Kosmetologii I Ochrony Zdrowia ^*  (Poland)

Author keywords

Cardiovascular disease; Fatty acids; Prostaglandins; Traumatic acid

Indexed keywords

ARACHIDONIC ACID; DICARBOXYLIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRAUMATIC ACID; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

CARDIOVASCULAR SYSTEM; CELL DIVISION; EXTRACELLULAR MATRIX; FATTY ACID METABOLISM; FATTY ACID OMEGA OXIDATION; GENE EXPRESSION; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; LIPID COMPOSITION; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 77953441827     PISSN: 18969666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Gajewska-Meszaros S, Meszaros J. Ryby morskie i owoce morza: luksus czy konieczność. Terapia i Leki 2001; 2: 26-31.
2. Sinclair HM. Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet 1956; 270: 381-3.
3. Witte KK, Clark AL. Wielonienasycone kwasy tłuszczowe z ryb morskich w leczeniu niewydolności serca. Pol Arch Med Wewn 2009; 3: 1-7.
4. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2: 757-61.
5. Holman RT. The slow discovery of the importance of omega 3 essential fatty acids in human health. J Nutr 1998; 128 (2 Suppl): 427S-33S.
6. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54: 438-63.
7. Stołyhwo-Szpajer M, Piȩkosz K, Bellwon J, et al. Wielonienasycone kwasy tłuszczowe i ich wpływ na czynniki ryzyka miażdżycy ze szczególnym uwzglȩdnieniem ciśnienia tȩtniczego. Nadciśnienie Tȩtnicze 2001; 5: 211-9.
8. Dominiczak AF, Bohr DF. Cell membrane abnormalities and the regulation of intracellular calcium concentration in hypertension. Clin Sci (Lond) 1990; 79: 415-23.
9. Russo C, Olivieri O, Girelli D, et al. Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension. Hypertension 1997; 29: 1058-63.
10. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274: 1363-7.
11. Vandongen R, Mori TA, Burke V, et al. Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease. Hypertension 1993; 22: 371-9.
12. Grimsgaard S, Bo/naa KH, Hansen JB, Myhere ES. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 1998; 68: 52-9.
13. Nishimura M, Nanbu A, Komori T, et al. Eicosapentaenoic acid stimulates nitric oxide production and decreases cardiac noradrenaline in diabetic rats. Clin Exp Pharmacol Physiol 2000; 27: 618-24.
14. Kang JX, Leaf A. Prevention and termination of the beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochem Biophys Res Commun 1995; 208: 629-36.
15. + channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A 1995; 92: 11000-4.
16. Kang JX, Xiao YF, Leaf A. Free, long chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 1995; 92: 3997-4001.
17. Kang JX, Leaf A. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr 2000; 71 (1 Suppl): S202-7.
18. 2+)-ATPase activity. Jpn Circ J 1994; 58: 903-12.
19. Den Ruijter HM, Berecki G, Verkerk AO, et al. Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation 2008; 117: 536-44.
20. Düsing R, Struck A, Göbel BO, et al. Effects of n-3 fatty acids on renal function and renal prostaglandin E metabolism. Kidney Int 1990; 38: 315-9.
21. Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J 2000; 21: 521-32.
22. Bagga D, Wang L, Farias-Eisner R, et al. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003; 100: 1751-6.
23. Shimizu T, Iwamoto T, Itou S, et al. Effect of ethyl icosapentaenoate (EPA) on the concentration of tumor necrosis factor (TNF) and interleukin-1 (IL-1) in the carotid artery of culf-sheathed rabbit models. J Atheroscler Thromb 2001; 8: 45-9.
24. Pakala R, Pakala R, Sheng WL, Benedict CR. Vascular smooth muscle cells preloaded with eicosapentaenoic acid and docosahexaenoic acid fail to respond to serotonin stimulation. Atherosclerosis 2000; 153: 47-57.
25. James MJ, Cleland LG, Gibson RA, Hawkes JS. Interaction between fish and vegetable oils in the relation to rat leukocyte leukotriene production. J Nutr 1991; 121: 631-7.
26. Mezzano D, Kosiel K, Martínez C, et al. Cardiovascular risk factors in vegetarians. Normalization of hyperhomocysteinemia with vitamin B (12) and reduction of platelet aggregation with n-3 fatty acids. Thromb Res 2000; 100: 153-60.
27. Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis 2003; 166: 85-93.
28. Svaneborg N, Kristensen SD, Hansen LM, et al. The acute and short-time effect of supplementation with the combination of n-3 fatty acids and acetylsalicylic acid on platelet function and plasma lipids. Thromb Res 2002; 105: 311-6.
29. Mayer K, Merfels M, Muhly-Reinholz M, et al. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am J Physiol Heart Circ Physiol 2002; 283: H811-8.
30. Kohno M, Ohmori K, Wada Y, et al. Inhibition by eicosapentaenoic acid of oxidized-LDL- and lysophosphatidylcholine-induced human coronary artery smooth muscle cell production of endothelin. J Vasc Res 2001; 38: 379-88.
31. English J Jr, Bonner J, Haagen-Smit AJ. Structure and synthesis of a plant wound hormone. Science 1939; 90: 329.
32. English J Jr, Bonner J. The wound hormones of plants. I. Traumatin, the active principle of the bean test. J Biol Chem 1937; 121: 791-9.
33. Pietryczuk A, Czerpak R. Wystȩpowanie, biosynteza i aktywność biologiczna kwasu traumatynowego u roślin. Post Biol Kom 2006; 33: 591-601.
34. Bate NJ, Sivasankar S, Moxon C, et al. Molecular characterization of an Arabidopsis gene encoding hydroperoxide lyase, a cytochrome P-450 that is wound inducible. Plant Physiol 1998; 117: 1393-400.
35. Grekchin AN. Recent developments in biochemistry of the plant lipoxygenase pathway. Prog Lipid Res 1998; 37: 317-52.
36. Zimmerman DC, Coudron CA. Identification of traumatin, a wound hormone, as 12-oxo-trans-10-dodecenoic acid. Plant Physiol 1979; 63: 536-41.
37. Ferdinandusse S, Denis S, Van Roermund CW, et al. Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of long-chain dicarboxylic acids. J Lipid Res 2004; 45: 1104-11.
38. Hardwick JP. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol 2008; 75: 2263-75.
39. Asafova EV, Asaleeva GA, Yakovleva VG, Tarchevskii IA. The effect of traumatic acid on tyrosine phosphorylation of proteins in pea seedlings. Dokl Biochem Biophys 2005; 405: 426-8.
40. Pietryczuk A, Piotrowska A, Czerpak R. The influence of traumatic acid on the growth and metabolite content of the green alga Chlorella vulgaris Beijerinck. Oceanol Hydrobiol Stud 2008; 37: 3-15.